Iovance Biotherapeutics Inc is a company in the U.S. stock market and it is a holding in 41 U.S.-traded ETFs. IOVA has around 11.5M shares in the U.S. ETF market. The largest ETF holder of IOVA is the iShares Russell 2000 ETF (IWM), with approximately 2.55M shares. Investors may also find of interest that the ETF with the largest allocation to IOVA stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 4.29%. On average, U.S. ETFs allocate 0.47% of IOVA to their portfolios.
Additionally, IOVA is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with IOVA as a holding is the Vanguard Total Stock Market ETF (VTI), with a return of 9.53%.